Home LiteratureArticle Details
PMID: 20554627 Published · ppublish English Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Replication of CLU, CR1, and PICALM associations with alzheimer disease.

Archives of neurology ·Vol. 67 ·No. 8 ·2010-08-00 ·Pages 961-4

Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, Crook JE, Pankratz VS, Dickson DW, Graff-Radford NR, Petersen RC, Morgan K, Younkin SG

Abstract

To test for replication of the association between variants in the CLU, CR1, and PICALM genes with Alzheimer disease. Follow-up case-control association study. The Mayo Clinics at Jacksonville, Florida, and Rochester, Minnesota. Community-based patients of European descent with late-onset Alzheimer disease (LOAD) and controls without dementia who were seen at the Mayo clinics, and autopsy-confirmed cases and controls whose pathology was evaluated at the Mayo Clinic in Jacksonville. Additional samples were obtained from the National Cell Repository for Alzheimer Disease (NCRAD). A total of 1829 LOAD cases and 2576 controls were analyzed. The most significant single-nucleotide polymorphisms in CLU (rs11136000), CR1 (rs3818361), and PICALM (rs3851179) were tested for allelic association with LOAD. Main Outcome Measure Clinical or pathology-confirmed diagnosis of LOAD. Odds ratios for CLU, CR1, and PICALM were 0.82, 1.15, and 0.80, respectively, comparable in direction and magnitude with those originally reported. P values were 8.6 x 10(-5), .014, and 1.3 x 10(-5), respectively; they remain significant even after Bonferroni correction for the 3 single-nucleotide polymorphisms tested. These results show near-perfect replication and provide the first additional evidence that CLU, CR1, and PICALM are associated with the risk of LOAD.

MeSH Terms
Alzheimer Disease/genetics,pathology Case-Control Studies Clusterin/genetics Follow-Up Studies Gene Frequency Genetic Predisposition to Disease Genome-Wide Association Study Genotype Humans Monomeric Clathrin Assembly Proteins/genetics Odds Ratio Polymorphism, Single Nucleotide/genetics Receptors, Complement 3b/genetics Residence Characteristics Whites
Chemicals
CLU protein, human CR1 protein, human Clusterin Monomeric Clathrin Assembly Proteins PICALM protein, human Receptors, Complement 3b
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Carrasquillo Minerva M
Department of Neuroscience, Mayo Clinic, 4500 San Pablo Rd, Birdsall Building, Jacksonville, FL 32224, USA.
Belbin Olivia
Hunter Talisha A
Ma Li
Bisceglio Gina D
Zou Fanggeng
Crook Julia E
Pankratz V Shane
Dickson Dennis W
Graff-Radford Neill R
Petersen Ronald C
Morgan Kevin
Younkin Steven G
References (22)
22 references, click to expand
  1. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.
    Proc Natl Acad Sci U S A. 1998 May 26;95(11):6448-53 PMID: 9600986
  2. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family.
    Proc Natl Acad Sci U S A. 1996 May 14;93(10):4804-9 PMID: 8643484
  3. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
    JAMA. 1997 Oct 22-29;278(16):1349-56 PMID: 9343467
  4. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.
    Nat Genet. 2009 Oct;41(10):1088-93 PMID: 19734902
  5. Apolipoprotein J and Alzheimer's amyloid beta solubility.
    Biochem J. 1996 Jun 1;316 ( Pt 2):671-9 PMID: 8687416
  6. Role of genes and environments for explaining Alzheimer disease.
    Arch Gen Psychiatry. 2006 Feb;63(2):168-74 PMID: 16461860
  7. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.
    Neurology. 1993 Aug;43(8):1467-72 PMID: 8350998
  8. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.
    Nat Genet. 2009 Oct;41(10):1094-9 PMID: 19734903
  9. Genome-wide association studies in Alzheimer's disease.
    Hum Mol Genet. 2009 Oct 15;18(R2):R137-45 PMID: 19808789
  10. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
    Science. 1993 Aug 13;261(5123):921-3 PMID: 8346443
  11. Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.
    Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4229-34 PMID: 8633046
  12. Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic.
    Mol Biol Cell. 1999 Aug;10(8):2687-702 PMID: 10436022
  13. Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta.
    Biochem Biophys Res Commun. 1994 Dec 15;205(2):1431-7 PMID: 7802679
  14. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease.
    Nat Genet. 2009 Feb;41(2):192-8 PMID: 19136949
  15. Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10843-8 PMID: 12145324
  16. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex.
    Biochem J. 1993 Jul 1;293 ( Pt 1):27-30 PMID: 8328966
  17. Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid.
    Neurosci Lett. 1995 May 19;191(1-2):79-82 PMID: 7659297
  18. Clusterin (Apo J) protects against in vitro amyloid-beta (1-40) neurotoxicity.
    J Neurochem. 1996 Sep;67(3):1324-7 PMID: 8752142
  19. The current status of Alzheimer's disease genetics: what do we tell the patients?
    Pharmacol Res. 2004 Oct;50(4):385-96 PMID: 15304236
  20. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.
    Neurology. 1984 Jul;34(7):939-44 PMID: 6610841
  21. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease.
    Nat Genet. 2007 Feb;39(2):168-77 PMID: 17220890
  22. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.
    Nat Genet. 2007 Jan;39(1):17-23 PMID: 17192785
Article Info
Journal
Archives of neurology
Abbr.
Arch Neurol
ISSN
1538-3687
Published
2010-08-00
Epub
2010-00-14
Pages
961-4
Language
English
Region
United States
NLM ID
0372436
PMCID
PMC2919638
Subset
IM
Grants
NIA NIH HHS · P50 AG16574 · United States
NIA NIH HHS · R01 AG018023-07 · United States
NIA NIH HHS · U24 AG021886 · United States
NIA NIH HHS · P50 AG016574 · United States
NIA NIH HHS · P50 AG016574-100006 · United States
NIA NIH HHS · P01 AG003949-250009 · United States
NIA NIH HHS · U01 AG006786-24 · United States
NIA NIH HHS · U01 AG06576 · United States
NIA NIH HHS · AG25711 · United States
NIA NIH HHS · P01 AG003949 · United States
NIA NIH HHS · P01 AG017216 · United States
NIA NIH HHS · R01 AG018023 · United States
NIA NIH HHS · AG03949 · United States
NIA NIH HHS · P01 AG017216-079001 · United States
NIA NIH HHS · P50 AG025711-059003 · United States
NIA NIH HHS · R01AG18023 · United States
NIA NIH HHS · U24 AG21886 · United States
NIA NIH HHS · P50 AG025711 · United States
NIA NIH HHS · U24 AG021886-02 · United States
NIA NIH HHS · U01 AG006786 · United States
NIA NIH HHS · AG17216 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]